ABSTRACT
Objective: To explore the clinical effects of ultrasound-guided adductor block (UGAB) on postoperative analgesia after total knee replacement. Methods: From March 2022 to June 2022, 60 patients in the First Affiliated Hospital of Chongqing Medical University were included. They were divided into control (n = 30) and ultrasonic groups (n = 30). They all received total knee arthroplasty. Before total knee arthroplasty, patients in the control and ultrasonic groups underwent general anesthesia and UGAB, respectively. Visual Analogue Scale (VAS) was used to assess the pain. The time of the first straight leg elevation and the first landing time were recorded. Knee joint function was evaluated. Information about the dosage of tramadol intramuscular injection and the number of times patient-controlled analgesia pump pressing was collected. The serum levels of interleukin-6 (IL-6) and high-sensitivity C-reactive protein (hs-CRP) were detected. Results: Compared with the control group, UGAB increased the rate of muscle contraction and relaxation and total and relaxation after total knee replacement in the ultrasonic group (P < .05). UGAB reduced VAS scores of pain during passive activity after operation (P < .05). UGAB also facilitated the first straight leg lifting time after the operation and the time of the first landing after the operation (P < .05). Meanwhile, UGAB reduced the dose of tramadol and press times of the self-control analgesia pump after operation (P < 0.05). UGAB also suppressed postoperative IL-6 and hs-CRP levels and increased postoperative joint range of motion (P < .05). Conclusion: UGAB promotes early recovery of knee function with high safety in patients undergoing total knee replacement, with reduced postoperative pain and inflammatory reaction.
Subject(s)
Analgesia , Arthroplasty, Replacement, Knee , Nerve Block , Tramadol , Humans , Tramadol/therapeutic use , C-Reactive Protein , Interleukin-6 , Pain, Postoperative/drug therapy , Pain, Postoperative/prevention & control , Ultrasonography, Interventional , Anesthetics, LocalABSTRACT
Objective: To review antibacterial/osteogenesis dual-functional surface modification strategy of titanium-based implants, so as to provide reference for subsequent research. Methods: The related research literature on antibacterial/osteogenesis dual-functional surface modification strategy of titanium-based implants in recent years was reviewed, and the research progress was summarized based on different kinds of antibacterial substances and osteogenic active substances. Results: At present, the antibacterial/osteogenesis dual-functional surface modification strategy of titanium-based implants includes: â Combined coating strategy of antibiotics and osteogenic active substances. It is characterized in that antibiotics can be directly released around titanium-based implants, which can improve the bioavailability of drugs and reduce systemic toxicity. â¡ Combined coating strategy of antimicrobial peptides and osteogenic active substances. The antibacterial peptides have a wide antibacterial spectrum, and bacteria are not easy to produce drug resistance to them. ⢠Combined coating strategy of inorganic antibacterial agent and osteogenic active substances. Metal ions or metal nanoparticles antibacterial agents have broad-spectrum antibacterial properties and various antibacterial mechanisms, but their high-dose application usually has cytotoxicity, so they are often combined with substances that osteogenic activity to reduce or eliminate cytotoxicity. In addition, inorganic coatings such as silicon nitride, calcium silicate, and graphene also have good antibacterial and osteogenic properties. ⣠Combined coating strategy of metal organic frameworks/osteogenic active substances. The high specific surface area and porosity of metal organic frameworks can effectively package and transport antibacterial substances and bioactive molecules. ⤠Combined coating strategy of organic substances/osteogenic active substancecs. Quaternary ammonium compounds, polyethylene glycol, N-haloamine, and other organic compounds have good antibacterial properties, and are often combined with hydroxyapatite and other substances that osteogenic activity. Conclusion: The factors that affect the antibacterial and osteogenesis properties of titanium-based implants mainly include the structure and types of antibacterial substances, the structure and types of osteogenesis substances, and the coating process. At present, there is a lack of clinical verification of various strategies for antibacterial/osteogenesis dual-functional surface modification of titanium-based implants. The optimal combination, ratio, dose-effect mechanism, and corresponding coating preparation process of antibacterial substances and bone-active substances are needed to be constantly studied and improved.
Subject(s)
Anti-Bacterial Agents , Metal-Organic Frameworks , Titanium , Anti-Bacterial Agents/pharmacology , Coated Materials, Biocompatible/chemistry , Metal-Organic Frameworks/pharmacology , Osteogenesis , Surface Properties , Titanium/chemistry , Titanium/pharmacology , Prostheses and ImplantsABSTRACT
Here, we report the simple construction of a supramolecular glycomaterial for the targeted delivery of antibiotics to P. aeruginosa in a photothermally-controlled manner. A galactose-pyrene conjugate (Gal-pyr) was developed to self-assemble with graphene nanoribbon-based nanowires via π-π stacking to produce a supramolecular glycomaterial, which exhibits a 1250-fold enhanced binding avidity toward a galactose-selective lectin when compared to Gal-pyr. The as-prepared glycomaterial when loaded with an antibiotic that acts as an inhibitor of the bacterial folic acid biosynthetic pathway eradicated P. aeruginosa-derived biofilms under near-infrared light irradiation due to the strong photothermal effect of the nanowires accelerating antibiotic release.
Subject(s)
Graphite , Nanotubes, Carbon , Graphite/chemistry , Anti-Bacterial Agents , Galactose , PhototherapyABSTRACT
BACKGROUND: Heroin addiction and withdrawal have been associated with an increased risk for infectious diseases and psychological complications. However, the changes of metabolites in heroin addicts during withdrawal remain largely unknown. METHODS: A total of 50 participants including 20 heroin addicts with acute abstinence stage, 15 with protracted abstinence stage and 15 healthy controls, were recruited. We performed metabolic profiling of plasma samples based on ultraperformance liquid chromatography coupled to tandem mass spectrometry to explore the potential biomarkers and mechanisms of heroin withdrawal. RESULTS: Among the metabolites analyzed, omega-6 polyunsaturated fatty acids (linoleic acid, dihomo-gamma-linolenic acid, arachidonic acid, n-6 docosapentaenoic acid), omega-3 polyunsaturated fatty acids (docosahexaenoic acid, docosapentaenoic acid), aromatic amino acids (phenylalanine, tyrosine, tryptophan), and intermediates of the tricarboxylic acid cycle (oxoglutaric acid, isocitric acid) were significantly reduced during acute heroin withdrawal. Although majority of the metabolite changes could recover after months of withdrawal, the levels of alpha-aminobutyric acid, alloisoleucine, ketoleucine, and oxalic acid do not recover. CONCLUSIONS: In conclusion, the plasma metabolites undergo tremendous changes during heroin withdrawal. Through metabolomic analysis, we have identified links between a framework of metabolic perturbations and withdrawal stages in heroin addicts.
Subject(s)
Heroin Dependence/blood , Heroin/toxicity , Metabolomics , Substance Withdrawal Syndrome/blood , Adult , Amino Acids, Aromatic/blood , Biomarkers/blood , Case-Control Studies , Fatty Acids, Omega-3/blood , Fatty Acids, Omega-6/blood , Humans , Male , Tricarboxylic Acids/bloodABSTRACT
BACKGROUND: The purpose of this study was to explore the clinical value of miR-378c and its target gene YY1 in gastric cancer. METHODS: The TCGA database was employed to analyse miR-378c expression in gastric cancer. qRT-PCR was applied to identify miR-378c and YY1 in tissues and serum of patients suffering from gastric cancer. The association of miR-378c with the clinical data of patients with gastric cancer was analysed. Receiver operating characteristics (ROC) curve analysis was used to determine the diagnostic value of miR-378c and YY1 in gastric cancer, and analyse the relationship between miR-378c and YY1 and patients' survival. Pearson's test was applied to determine the association between miR-378c and YY1 in tissue and serum of patients. Dual-Luciferase Reporter assay was employed to examine the targeting association between miR-378c and YY1. Finally, independent prognostic factors was determined in patients with gastric cancer using Cox regression analysis. RESULTS: In the TCGA database, miR-378c was weakly expressed in gastric cancer. Overall, patients with low expression had a lower survival rate. The expression of miR-378c decreased and the expression of YY1 increased in cancer tissues and serum of tumour patients. In patients with low expression of miR-378c the tumour size was ≥ 5 cm. Low differentiation, high TNM staging and lymph node invasion rate increased significantly, but the 5-year survival rate decreased in the patients. miR-378c and YY1 had better diagnostic value in gastric cancer. TargetScan, miRDB, starBase and miRTarBase predicted that YY1 was a potential gene of miR-378c, and the Dual-Luciferase Reporter assay revealed that there was a targeting relationship between the two, which was proved by correlation analysis. Multivariate Cox analysis revealed that differentiation, TNM staging and miR-378c were independent prognostic factors for patients. CONCLUSIONS: MiR-378c is weakly expressed in gastric cancer patients and may be considered as a promising diagnostic and prognostic indicator for gastric cancer.
Subject(s)
MicroRNAs/metabolism , Stomach Neoplasms/diagnosis , YY1 Transcription Factor/metabolism , Area Under Curve , Biomarkers, Tumor/blood , Biomarkers, Tumor/genetics , Biomarkers, Tumor/metabolism , Databases, Factual , Female , Gene Expression Regulation, Neoplastic , Humans , Lymphatic Metastasis , Male , MicroRNAs/blood , MicroRNAs/chemistry , Middle Aged , Neoplasm Staging , Prognosis , Proportional Hazards Models , ROC Curve , Stomach Neoplasms/genetics , Stomach Neoplasms/metabolism , Stomach Neoplasms/mortality , Survival Rate , YY1 Transcription Factor/chemistry , YY1 Transcription Factor/geneticsABSTRACT
BACKGROUND: Despite the administration of prophylactic antiemetics, some patients who undergo laparoscopic sleeve gastrectomy (LSG) remain at high risk for postoperative nausea and vomiting (PONV). Although many trials have been conducted, the effectiveness of transcutaneous electrical acupoint stimulation (TEAS) on the prevention of PONV remains unknown. METHODS: Sixty-two female patients undergoing elective LSG were randomly assigned to the TEAS combined with dexamethasone and tropisetron (TEAS group, n = 31) or dexamethasone and tropisetron (control group, n = 31) groups. The incidence and severity of PONV, as well as the need for rescue antiemetics, were collected within 48 h after surgery. RESULTS: The patients in both groups had similar clinical characteristics and underwent the same surgical procedure. In the TEAS group, 13 patients (41.9%) had PONV within 48 h after LSG compared to 24 patients (77.4%) in the control group (P = 0.004, relative risk: 0.39 [0.19, 0.80]). The severity of PONV differed significantly between groups, with five patients (16.1%) in the TEAS group and 15 patients (48%) in the control group experiencing clinically important PONV (P = 0.007, relative risk: 0.62 [0.42, 0.90]). Moreover, fewer patients required antiemetic rescue medication in the TEAS group compared with the control group (29.0% vs. 58.1%, P = 0.021). CONCLUSION: Multimodal antiemetic prophylaxis consisting of TEAS and antiemetics was effective in reducing PONV incidence and intensity in high-risk patients undergoing LSG.
Subject(s)
Antiemetics , Laparoscopy , Obesity, Morbid , Acupuncture Points , Dexamethasone , Double-Blind Method , Female , Gastrectomy/adverse effects , Humans , Obesity, Morbid/surgery , Postoperative Nausea and Vomiting/prevention & control , Prospective Studies , TropisetronABSTRACT
Aflibercept, as a soluble decoy vascular endothelial growth factor receptor, Which has been used as a first-line monotherapy for cancers. Aflibercept often causes cardiovascular toxicities including hypertension, but the mechanisms underlying aflibercept-induced hypertension remain unknown. In this study we investigated the effect of short-term and long-term administration of aflibercept on blood pressure (BP), vascular function, NO bioavailability, oxidative stress and endothelin 1 (ET-1) in mice and cultured endothelial cells. We showed that injection of a single-dose of aflibercept (18.2, 36.4 mg/kg, iv) rapidly and dose-dependently elevated BP in mice. Aflibercept treatment markedly impaired endothelial-dependent relaxation (EDR) and resulted in NADPH oxidases 1 (NOX1)- and NADPH oxidases 4 (NOX4)-mediated generation of ROS, decreased the activation of protein kinase B (Akt) and endothelial nitric oxide synthase (eNOS) concurrently with a reduction in nitric oxide (NO) production and elevation of ET-1 levels in mouse aortas; these effects were greatly attenuated by supplementation of L-arginine (L-arg, 0.5 or 1.0 g/kg, bid, ig) before aflibercept injection. Similar results were observed in L-arg-pretreated cultured endothelial cells, showing markedly decreased ROS accumulation and AKT/eNOS/NO signaling impairment induced by aflibercept. In order to assess the effects of long-term aflibercept on hypertension and to evaluate the beneficial effects of L-arg supplementation, we administered these two drugs to WT mice for up to 14 days (at an interval of two days). Long-term administration of aflibercept resulted in a sustained increase in BP and a severely impaired EDR, which are associated with NOX1/NOX4-mediated production of ROS, increase in ET-1, inhibition of AKT/eNOS/NO signaling and a decreased expression of cationic amino acid transporter (CAT-1). The effects caused by long-term administration were greatly attenuated by L-arg supplementation in a dose-dependent manner. We conclude that aflibercept leads to vascular dysfunction and hypertension by inhibiting CAT-1/AKT/eNOS/NO signaling, increasing ET-1, and activating NOX1/NOX4-mediated oxidative stress, which can be suppressed by supplementation of L-arg. Therefore, L-arg could be a potential therapeutic agent for aflibercept-induced hypertension.
Subject(s)
Arginine/pharmacology , Hypertension/chemically induced , Nitric Oxide Synthase Type III/metabolism , Nitric Oxide/metabolism , Recombinant Fusion Proteins/adverse effects , Vascular Diseases/chemically induced , Animals , Aorta/metabolism , Aorta/pathology , Human Umbilical Vein Endothelial Cells , Humans , Hypertension/metabolism , Hypertension/physiopathology , Male , Mice , Mice, Inbred C57BL , Proto-Oncogene Proteins c-akt/metabolism , Receptors, Vascular Endothelial Growth Factor , Recombinant Fusion Proteins/pharmacology , Signal Transduction/drug effects , Vascular Diseases/metabolism , Vascular Diseases/physiopathologyABSTRACT
An aza-15-crown-5-ether functionalized bisthienylethene (BTE-15C5) was synthesized, which can reversibly capture and release calcium ions by UV/Vis irradiation. After doping this photochromic bisthienylethene with a two-component lecithin-Ca(2+) organogel, the original deep-blue gel changed to light-blue fluid due to the cooperative binding with Ca(2+) by the open-form bisthienylethene dopant. Upon UV irradiation, the closed isomer was formed which released the Ca(2+) and the organogel was retrieved. Hence, a novel organic simple doped-type three-component photo-induced gel-to-sol transition system was constructed.
Subject(s)
Calcium/chemistry , Ethylenes/chemistry , Lecithins/chemistry , Micelles , Photochemical Processes , Thiophenes/chemical synthesis , Gels/chemistry , Ions , Molecular Structure , Thiophenes/chemistryABSTRACT
BACKGROUND: Iodine 125 (125I) seed irradiation can be used as an important supplementary treatment for unresectable advanced gastric cancer. Here, we aim to comprehensively elucidate the biological effects induced by 125I seed irradiation in human gastric cancer xenograft model by using global expression and DNA methylation analyses. METHODS: The 48 mice bearing NCI-N87 gastric cancer xenografts were randomly separated into 2 groups: sham seeds (O mCi) were implanted into the control group (n = 24); 125 l seeds (0.9 mCi) were implanted into the treatment group (n = 24). The mitotic index and apoptotic index were evaluated by quantitative morphometric analysis of the expression of proliferating cell nuclear antigen (PCNA) and in situ terminal transferase-mediated fluorescein deoxy- UTP nick end labeling (TUNEL), respectively. Global gene expression changes induced by 125I seed irradiation were analyzed by using Nimblegen Human gene expression array. DNA methylation profile in the tumors from control group was investigated with methylated DNA immunoprecipitation (MeDIP) and Nimblegen CpG promoter microarrays. The changes in the methylation status of selected genes were further investigated by using MeDIP-PCR. RESULTS: 125I seed irradiation suppresses the growth of gastric cancer xenografts in nude mice. PCNA staining and tissue TUNEL assays showed that both inhibition of cell proliferation and induction of apoptosis contribute to the 125I-induced tumor suppression in nude mouse model. Gene expression profiles revealed that the expression levels of several hundred genes, many of which are associated with apoptosis or cell cycle arrest, including BMF, MAPK8, BNIP3, RFWD3, CDKN2B and WNT9A, were upregulated following 125I seed irradiation. Furthermore, the up-regulation of some of these genes, such as BNIP3 and WNT9A, was found to be associated with irradiation-induced DNA demethylation. CONCLUSIONS: This study revealed that 125I seed irradiation could significantly induce the up-regulation of apoptosis- and cell cycle-related genes in human gastric cancer xenografts. And some of the up-regulation might be attributed to 125I-irradiation induced demethylation in gene promoter regions. Collectively, these findings provided evidence for the efficacy of this modality for the treatment of gastric cancer.
Subject(s)
Cell Proliferation/radiation effects , Gene Expression Regulation, Neoplastic/radiation effects , Iodine Radioisotopes , Stomach Neoplasms , Animals , Apoptosis/genetics , Apoptosis/radiation effects , Cell Cycle Checkpoints/genetics , Cell Cycle Checkpoints/radiation effects , DNA Methylation/radiation effects , Humans , Mice , Mice, Nude , Stomach Neoplasms/genetics , Stomach Neoplasms/metabolism , Stomach Neoplasms/radiotherapy , Transplantation, Heterologous , Up-RegulationABSTRACT
The intestinal permeability of eight sesquiterpenes which are active constituents of some traditional Chinese medicines, were studied by using the Caco-2 cell monolayer; they include tanacetin, artesin, magnolialide, crossostephin, atractylon, isocalamenediol (ICL), bisabolangelone (BSE) and (3 R)-des- O-methyllasiodiplodin (DML). The bidirectional permeability of the eight sesquiterpenes was studied from the apical (AP) side to the basolateral (BL) side or from the BL side to the AP side. The eight compounds were assayed by HPLC. Transport parameters and apparent permeability coefficients ( P(app)) were then calculated. The bidirectional P(app) values of the eight compounds were compared with those of propranolol, a marker of high permeability and transcellular transport. The transport of the eight sesquiterpenes was concentration-dependent in the range of 10-200 microM. Lower recoveries of ICL, BSE and DML than other sesquiterpenes were found during transport. The results indicated that all the sesquiterpenes are well absorbed mainly by the passive diffusion via the transcellular pathway and metabolism may be involved during the absorption of ICL, BSE and DML.
Subject(s)
Drugs, Chinese Herbal/pharmacokinetics , Intestinal Absorption , Sesquiterpenes/pharmacokinetics , Biological Transport , Caco-2 Cells , Cell Membrane Permeability , Chromatography, High Pressure Liquid , Diffusion , Dose-Response Relationship, Drug , Drugs, Chinese Herbal/chemistry , Humans , Propranolol , Sesquiterpenes/isolation & purificationABSTRACT
OBJECTIVE: To investigate the chemical constituents of 70% aqueous ethanol extract from the whole plant of Crossostephium chinense for inhibitory activity against alpha-glucosidase. METHOD: A bioactivity-guided isolation and purification process was used to identify the alpha-glucosidase activity inhibiting components of the whole plant of C. chinense. The dried whole plants were extracted with 70% aqueous ethanol. The extract was suspended in water and then further fractionated successively with cyclohexane, ethyl acetate, and normal butanol,and tested for their inhibitory activity against alpha-glucosidase in vitro. The chemical structures of isolated compounds were determined by spectroscopic methods including NMR and MS, and comparison with data of authentic samples. All of compounds were assayed for their inhibitory activity against alpha-glucosidase in vitro. RESULT: The ethyl acetate and water layer fractions showed the strong inhibitory activity, and were subjected to column chromatography over the various stationary phases. Tricetin 3',4',5'-trimethylether (1), scopoletin (2), tanacetin, hispidulin (3), apometzgerin (4), chrysoeriol (5), quercetagetin 3,6, 7-trimethylether (6), selagin (7) , scopolin (8), and quercetagetin-3,6-dimethylether (9) were isolated and characterized by different spectroscopic techniques. Among them, compounds 2, 3, 5-7 and 9 for inhibitory activity against alpha-glucosidase with IC50 (micromol x L(-1)) values of (34.36 +/- 2.06), (146.28 +/- 12.44), (246.26 +/- 8.73), (74.06 +/- 3.83), (42.19 +/- 5.25) and (136.20 +/- 25.73), respectively, were assayed as the active components. A positive drug, acarbose, showed the inhibitory activity against alpha-glucosidase with IC50 value of (489.25 +/- 38.55) mciromol x L(-1) in the same assay conditions with the above test com-1) pounds. The IC50 values of compounds 1, 4, 8 and tanacetin were all more than 1 000 micromol x L(-1). CONCLUSION: The compounds 5 and 9 were isolated from the genus Crossostephium for the first time. The compounds 2, 3, 5-7, and 9 showed the strong inhibitory activity against alpha-glucosidase in vitro in the simple competitive manner. The results indicated that these compounds may be involved in the treatment of diabetes in the whole plant of C. chinense for human.
Subject(s)
Asteraceae/chemistry , Enzyme Inhibitors/chemistry , Enzyme Inhibitors/isolation & purification , Glycoside Hydrolase Inhibitors , Plant Extracts/chemistry , Plant Extracts/isolation & purification , Kinetics , Protein Binding , alpha-Glucosidases/chemistryABSTRACT
OBJECTIVE: To investigate the effects of the chemical constituents of the whole herbs of Crossostephium chinense on insulin secretion in rat islets. METHOD: Islets were isolated from rat pancreata, cultured in vitro, and measured by color signals of dithizone stained digestion solution for detection of pancreatic islets. The morphological observation of islets was carried out by inverted microscope. The effects of test compounds, scopoletin (1), scopolin (2), tanacetin (3), quercetagetin-3,6,7-trimethylether (4) and 5-O-methyl-myo-inositol (5) isolated from the whole herbs of C. chinense, on the insulin secreting level from islets were compared with those of glybenclamide as a positive control substances, and the difference in insulin secreting level from islets between the presence and absence of test compounds was assayed. RESULT: There was no difference in basal insulin secretion before and after 2 h incubation period of rat islets. The islets treated with quercetagetin-3,6,7-trimethylether have about 2-fold higher insulin secreting level (P < 0.01) compared a normal control group. The islets treated with 5-O-methyl-myo-inositol have about 1.5-fold higher insulin secreting level (P < 0.05) compared to a normal control group. Whereas the islets treated with scopoletin show about 1.9-fold lower basal insulin secreting level (P < 0.05) than a normal control group. CONCLUSION: In this paper the developed cultivation method of isolated pancreatic islets from rat can be used as a kind of islet-based drug screening model for diabetes mellitus in vitro. Quercetagetin-3,6,7-trimethylether and 5-O-methyl-myo-inositol could enhance rat islet insulin secretion and further in vivo studies are needed to clarify the nature of such an observation. However, scopletin suppress rat islet insulin secretion.
Subject(s)
Asteraceae/chemistry , Drugs, Chinese Herbal/pharmacology , Insulin/metabolism , Islets of Langerhans/drug effects , Animals , Drugs, Chinese Herbal/chemistry , In Vitro Techniques , Insulin Secretion , Islets of Langerhans/metabolism , Male , Rats , Rats, Sprague-DawleyABSTRACT
OBJECTIVE: To investigate the effects of preconditioning and postconditioning with Shenfu Injection (SFI) on cognitive function in patients after valve replacement under extra-corporeal circulation. METHODS: Thirty-two patients prepared to receive valve replacement, aged 25-54 years, with heart function of II-III level, were randomly assigned to four groups, eight in each group. Patients in group E1 received SFI 1 mL/kg after intubation and before blocking the aorta; patients in group E2 received SFI 1 mL/kg after opening the aorta; patients in group E3 received SFI 0.5 mL/kg twice, at before blocking and after opening the aorta, respectively; and patients in group C received 1 mL/kg normal saline after intubation for control. All the medication was infused via pump. Venous blood samples were taken from the internal jugular venous bulb cannula for detecting plasma S100beta protein by ELISA at 6 different time points, i.e. after trachea intubation (T1), 10 min after cardiopulmonary bypass (CPB, T2), hypothermia stabilizing stage (T3), re-warming to 33 degrees C (T4), ending CPB (T5) and 1 h after ending CPB (T6). And patients' cognitive function was assessed for 4 times with mini-mental state examination (MMSE) scale, at the day before operation, and 1, 2, 7 days after operation. RESULTS: The elevation of S100beta plasma protein was lesser in the three E groups than that in group C (P < 0.05), and the lowest level was shown at T6 in Group E3 (P < 0.05). The highest incidence of cognitive dysfunction occurred in Group C one week after operation (P < 0.05). CONCLUSION: SFI may reduce the plasma level of S100B protein, maintain stable the structure and function of blood-brain barrier, it is favorable to the post-operational recovery of neurological function of patients, showing good brain protective effect. The optimal effect could be obtained by pump infusion of 0.5 mL/kg of SFI before aortic blocking and after aortic opening.
Subject(s)
Cognition Disorders/prevention & control , Drugs, Chinese Herbal/therapeutic use , Heart Valve Prosthesis Implantation , Postoperative Complications/prevention & control , Adult , Blood-Brain Barrier/drug effects , Brain/blood supply , Cardiopulmonary Bypass , Female , Humans , Ischemic Preconditioning , Male , Middle Aged , Nerve Growth Factors/blood , Phytotherapy , S100 Calcium Binding Protein beta Subunit , S100 Proteins/bloodABSTRACT
Eight compounds were isolated from the whole plants of Crossostephium chinense. Their structures were identified on the basis of analysis of spectral data. Eight compounds were taraxeryl acetate (1), taraxerol (2), alpha-amyrin acetate (3), beta-amyrin acetate (4), beta-sitosterol (5), 3beta-acetoxy-12-ursen-11-one (6), uracil (7) and 5-O-methyl-myo-inositol (8). Compounds 3-8 were isolated from the plant for the first time.
Subject(s)
Asteraceae/chemistry , Drugs, Chinese Herbal/chemistry , Magnetic Resonance Spectroscopy , Spectrometry, Mass, Electrospray Ionization , Triterpenes/analysisABSTRACT
BACKGROUND: Recent reports suggest that enteral diets enriched with arginine may be harmful by enhancing inflammation. This is consistent with our gut ischemia/reperfusion (I/R) model in which arginine induced the proinflammatory mediator inducible nitric oxide synthase and resulted in injury and inflammation whereas glutamine was protective. We now hypothesize that arginine and glutamine differentially modulate the early proinflammatory transcription factors activated by gut I/R. METHODS: At laparotomy, jejunal sacs were filled with either 60 mmol/L glutamine, arginine, or an iso-osmotic control followed by 60 minutes of superior mesenteric artery occlusion and 6 hours of reperfusion and compared with shams. Jejunum was harvested for nuclear factor (NF)-kappaB and activator protein-1 (AP-1) measured by electrophoretic mobility shift assay and c-jun and c-fos (AP-1 family) by supershift. RESULTS: Both NF-kappaB and AP-1 were activated by gut I/R. Arginine and glutamine had no differential effect on NF-kappaB, whereas AP-1 expression (c-jun but not c-fos) was markedly enhanced by arginine and significantly lessened by glutamine. CONCLUSION: Arginine enhanced expression of the early proinflammatory transcription factor AP-1 but not NF-kappaB. This represents a novel mechanism by which arginine may be harmful when administered to critically ill patients.
Subject(s)
Arginine/therapeutic use , Enteral Nutrition/methods , Glutamine/therapeutic use , Immunologic Factors/therapeutic use , Jejunum/drug effects , Mesenteric Vascular Occlusion/therapy , NF-kappa B/drug effects , Reperfusion Injury/therapy , Transcription Factor AP-1/drug effects , Analysis of Variance , Animals , Arginine/immunology , Disease Models, Animal , Drug Evaluation, Preclinical , Electrophoretic Mobility Shift Assay , Enteral Nutrition/adverse effects , Glutamine/immunology , Immunity, Mucosal/drug effects , Immunity, Mucosal/immunology , Immunologic Factors/immunology , Inflammation , Jejunum/blood supply , Jejunum/chemistry , Jejunum/immunology , Male , Mesenteric Artery, Superior , Mesenteric Vascular Occlusion/complications , Mesenteric Vascular Occlusion/immunology , NF-kappa B/analysis , NF-kappa B/immunology , Nitric Oxide Synthase/analysis , Nitric Oxide Synthase/drug effects , Nitric Oxide Synthase/immunology , Nitric Oxide Synthase Type II , Patient Selection , Peroxisome Proliferator-Activated Receptors/analysis , Peroxisome Proliferator-Activated Receptors/drug effects , Peroxisome Proliferator-Activated Receptors/immunology , Rats , Rats, Sprague-Dawley , Reperfusion Injury/complications , Reperfusion Injury/immunology , Risk Factors , Time Factors , Transcription Factor AP-1/analysis , Transcription Factor AP-1/immunologyABSTRACT
Gut ischemia-reperfusion (I/R) injury is a serious complication of shock. Previously we demonstrated that the administration of alpha-melanocyte-stimulating hormone (MSH) immediately before mesenteric I/R protected against postischemic gut injury. In this report, we tested the therapeutic efficacy of alpha-MSH on gut I/R (60 min ischemia, 6 h reperfusion) injury when given at different time points of reperfusion. Rats underwent sham surgery or were treated with saline or with alpha-MSH that was given 1, 2, or 4 h after superior mesenteric artery clamping. Vehicle-treated I/R rats exhibited severe mucosal injury and increased NF-kappaB DNA binding activity, myeloperoxidase (MPO) activity, and interleukin-6 and heme oxygenase-1 (HO-1) expression. In contrast, rats given alpha-MSH at 1 h of reperfusion, but not 2 h or 4 h, exhibited much less mucosal injury. Rats given alpha-MSH at 1 h or 2 h of reperfusion, but not 4 h, exhibited less MPO activity, NF-kappaB DNA binding activity, and interleukin-6 protein and even higher levels of heme oxygenase-1 than vehicle-treated rats. In addition, we found that combined use of alpha-MSH, a known inhibitor of IkappaBalpha tyrosine phosphorylation, with BAY 11-7085, an inhibitor of IkappaBalpha Ser 32,36 phosphorylation, abrogates gut MPO induction and tissue injury at early and late time points of reperfusion. Thus, alpha-MSH, an endogenous peptide with a favorable side-effect profile, is effective in treating experimental gut I/R injury when given early after the initial ischemia and may represent a candidate therapy for gut I/R in humans in whom recognition and treatment are often delayed.